Figure 1From: FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome Flow-FISH strategy results for representative patients with AML1/ETO (A) (sample #9) and CBFβ/MYH11 (B) (sample #21) in the blast population are illustrated. Back to article page